Navigation Links
Cephalon Reported Financial Results for the Second Quarter of 2011
Date:8/2/2011

exclude the change in fair value of the Ception Therapeutics, Inc. ($1.4M), BioAssets Development Company ($0.3M) and Gemin X Pharmaceuticals ($0.9M) contingent consideration.(5) To exclude costs related to restructurings.(6) In 2011, to exclude costs related to the impairments of AMRIX ($43.3M) and Mepha in-process research and development ($5.2M). (7) To exclude imputed interest expense associated with convertible debt.(8) In 2011, to exclude the change in fair value of our investments in Mesoblast Ltd. ($91.2M) and ChemGenex Pharmaceuticals Ltd. ($8.3M). (9) In 2011, to exclude costs and changes in fair value of certain derivative contracts ($16.5M).  In 2010, to exclude losses related to the acquisition of Mepha AG, including a loss on foreign exchange derivative instruments ($2.9M) and a loss on foreign exchange of Swiss Franc acquisition funds ($2.5M). (10) To reflect the tax effect of pre-tax adjustments at applicable tax rates and certain other tax adjustments primarily related to changes in valuation allowances and other changes in tax assets and liabilities.CEPHALON, INC. AND SUBSIDIARIESReconciliation of GAAP Net Income to Adjusted Net Income Attributable to Cephalon, Inc.(Unaudited)Six Months EndedJune 30,20112010GAAP NET INCOME ATTRIBUTABLE TO CEPHALON, INC.

$ 329,263$ 199,629Cost of sales adjustments

28,284

(1)

83,175

(1)Research and development adjustments

320

(2)

676

(2)Selling, general and administrative adjustments

25,704

(3)

11,502

(3)Change in fair value of contingent consideration adjustments

4,401

(4)

-Restructuring adjustment

5,137

(5)

5,325

(5)Acquired in-process research and development adjustments

30,000

(6)

-Impairment and (gain) loss on sale of assets adjustment

54,056

(7)

-Interest expense adjustment

31,691

(8)

36,055

(8)Chan
'/>"/>

SOURCE Cephalon, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. Cephalon Quarterly Conference Call Invitation
2. Cephalon Concludes All Outstanding Federal and State Government Investigations into the Companys Sales and Promotional Practices
3. $425 Million Cephalon Civil Settlement and Criminal Fine; In Americas Largest
4. Cephalon Launches National Consumer Awareness Initiative on Appropriate Use of Prescription Opioid Medications
5. Cephalon and Eurand Announce Notification of Generic Filing for Cyclobenzaprine Hydrochloride Extended-Release Capsules
6. Cephalon Reports Another Strong Quarter
7. Cephalon, Inc. to Webcast Analyst Day
8. Cephalon and Eurand File Patent Infringement Lawsuit Against Mylan Pharmaceuticals and Barr Pharmaceuticals
9. Cephalon Exercises Option to License Worldwide Rights to ImmuPharma Product, Lupuzor
10. Cephalon Appoints Sarma P. Duddu as General Manager and Vice President of Drug Delivery Technologies for CIMA LABS
11. Cephalons New Product Launches Pace Record 2008 Sales
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... PARIS , July 1, 2015 ... key developer of biotech crops, today announce a ... generations of insect control traits. "Growers ... the realities of advancing insect resistance. We are ... insect control technology with Genective,s capability in developing ...
(Date:7/1/2015)... ... ... The next-generation sequencing (NGS) clinical market is poised for huge growth as it prepares ... in its new report that the market drivers of this vibrant industry include increased ... diagnostics as part of a molecular diagnostics trend. , The global market is forecast ...
(Date:7/1/2015)... , July 1, 2015   Neuraltus Pharmaceuticals, ... development of groundbreaking drugs to treat neurodegenerative diseases ... that Robert G. Miller , M.D., Director of ... Health,s California Pacific Medical Center in San Francisco, has ... for $1.5 million to help fund a Phase ...
(Date:7/1/2015)... July 1, 2015 Isagenix International, a leading ... three Gold, three Silver, and three Bronze Stevie® Awards ... in Chicago this month.The ... business awards program in the U.S. ... strength in developing leaders, cultivating talent, creating a unified ...
Breaking Biology Technology:AgBiome and Genective collaborate to create novel insect-resistant crops 2NGS-Based Diagnostics, the ‘Must-Have Platform’, Sends Market Segment CAGRs Soaring According to BCC Research 2NGS-Based Diagnostics, the ‘Must-Have Platform’, Sends Market Segment CAGRs Soaring According to BCC Research 3Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 2Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 3Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 4Isagenix Earns Nine American Business Awards 2Isagenix Earns Nine American Business Awards 3
... ... Conference, BETHEL, Conn., Aug. 20 ... components to the,medical device industry, announced today that unaudited preliminary results,indicate revenue ... an increase of over 7% from the third quarter,and down slightly from ...
... 20 Baxa Corporation has,published the 2008 dates ... Resources) Center. The STAR Center, a premier facility,designed ... at,the company,s world headquarters south of Denver, Colorado. ... education on,pharmacy practice, cleanroom principles and compliance to ...
... VIENNA, Va., Aug. 20 CEL-SCI Corporation,(Amex: ... Financial Equity Conference in,Charleston, South Carolina. On ... Kersten, Chief Executive,Officer, will give a 25-minute presentation ... will also participate in a question,and answer session ...
Cached Biology Technology:Memry Corporation Announces Preliminary Fiscal Fourth Quarter and 2007 Revenue 2Memry Corporation Announces Preliminary Fiscal Fourth Quarter and 2007 Revenue 3Memry Corporation Announces Preliminary Fiscal Fourth Quarter and 2007 Revenue 4Baxa Announces 2008 Dates for STAR Center Professional Pharmacy and Cleanroom Training 2Baxa Announces 2008 Dates for STAR Center Professional Pharmacy and Cleanroom Training 3CEL-SCI to Present at the Noble Financial Conference 2
(Date:6/24/2015)... 2015 This report provides market analysis of ... years. It contains an analysis of the drivers, challenges, ... impact from the short, medium, and long term perspective ... market, and technology trends that currently, prevail in the ... authorities to efficiently manage the increasing marine traffic and ...
(Date:6/24/2015)... DUBLIN , June 22, 2015 ... has announced the addition of the "Huawei ... Analysis" report to their offering. ... going to the opposite direction than Apple,s and ... innovative fingerprint sensor developed by Fingerprint Cards, a ...
(Date:6/23/2015)... , June 23, 2015   MedNet ... that supports the entire spectrum of clinical research, ... ™ , the company,s intuitive, flexible ... awarded a Silver 2015 Stevie® Award by the ... Products & Services Website category.  The American Business ...
Breaking Biology News(10 mins):Automatic Identification System Market by Class, by Platform, by Application and by Geography - Global Forecasts & Analysis to 2014 - 2020 2Huawei Ascend Mate 7 Fingerprint Sensor - Reverse Costing Analysis 2MedNet Solutions' iMedNet eClinical Wins Silver Stevie Award 2
... June 1, 2009 REGiMMUNE Corporation today announced that ... low-dose of Sirolimus, demonstrated enhanced efficacy in transplantation tolerance ... disease (GvHD). This data is being presented today ... Liposomal Formulation of KRN7000 (RGI-2001) Alone and in Combination ...
... Biologists have for several years modeled how different species ... studies ignore differences between populations within a species and ... An article in the June issue of BioScience ... five colleagues, shows how these limitations can be avoided. ...
... Pennsylvania School of Medicine have uncovered variation around two genes ... Testicular cancer is the most common cancer among young men, ... the last 40 years -- it now affects seven out ... The discovery, published in the May 31, 2009 online issue ...
Cached Biology News:REGiMMUNE presents enhanced efficacy data in preclinical transplantation models 2Penn researchers discover genetic risk factor for testicular cancer 2Penn researchers discover genetic risk factor for testicular cancer 3
... MTT, (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrasodium bromide), 50mg/vial. MTT is ... by living cells to yield a dark ... mitochondria, and even freshly dead cells do ... A is a component of Chemicons MTT ...
Mouse polyclonal antibody to ALS2CR8 - amyotrophic lateral sclerosis 2 (juvenile) chromosome region, candidate 8...
Determin interaction of your protein with Echelons lipids...
Anti-Human Complement Component C4c, IgY fraction (Polyclonal) (chicken IgY)...
Biology Products: